EFFECT OF ONCE-WEEKLY RIFAPENTINE AND ISONIAZID ON THE PHARMACOKINETICS OF TWICE-DAILY DORAVIRINE IN HEALTHY VOLUNTEERS.

被引：0
|
作者：
Lam, E. [1 ]
Zheng, R. [1 ]
Schaefer, J. [2 ]
Kraft, W. [1 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Sidney Kimmel Med Coll, Philadelphia, PA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-009
引用
收藏
页码：S81 / S81
页数：1
相关论文
共 50 条
  • [21] Higher Completion Rates With Self-administered Once-weekly Isoniazid-rifapentine Versus Daily Rifampin in Adults With Latent Tuberculosis
    Haas, Michelle K.
    Aiona, Kaylynn
    Erlandson, Kristine M.
    Belknap, Robert W.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E3459 - E3467
  • [22] Is once-daily mesalazine equivalent to the currently used twice-daily regimen? A study performed in 30 healthy volunteers
    Gandia, Peggy
    Idier, Isabelle
    Houin, Georges
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (03): : 334 - 342
  • [23] Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid
    Vernon, A
    Burman, W
    Benator, D
    Khan, A
    Bozeman, L
    LANCET, 1999, 353 (9167): : 1843 - 1847
  • [24] Update of the Recommendations for the Use of Once-Weekly Isoniazid-Rifapentine Regimen to Latent Mycobaterium tuberculosis Infection
    Alabaz, Derya
    JOURNAL OF PEDIATRIC INFECTION, 2019, 13 (01): : E58 - E61
  • [25] The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteers
    Aarnoutse, RE
    Grintjes, KJT
    Telgt, DSC
    Stek, M
    Hugen, PWH
    Reiss, P
    Koopmans, PP
    Hekster, YA
    Burger, DM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (01) : 57 - 67
  • [26] Pharmacokinetics, Bioavailability and Safety of a Modified-Release Once-Daily Formulation of Tofacitinib in Healthy Volunteers.
    Lamba, M.
    Wang, R.
    Fletcher, T.
    Alvey, C.
    Hazra, A.
    Kushner, J.
    Larmann, J.
    Stock, T.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S649 - S650
  • [27] EFFECT OF CILOSTAZOL ON THE PHARMACOKINETICS OF SIMVASTATIN IN HEALTHY VOLUNTEERS.
    Ko, J.
    Jung, J.
    Kim, T.
    Kim, D.
    Kim, S.
    Kim, J.
    Ha, J.
    Kim, M.
    Lee, S.
    Huh, W.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S114 - S114
  • [28] Pregnancy Safety Assessment Of 3 Months Of Once-Weekly Rifapentine And Isoniazid And 9 Months Of Daily Isoniazid: A Post-Hoc Analysis Of The Prevent Tb And The Iadhere Trials
    Moro, R. N.
    Scott, N. A.
    Vernon, A.
    Goldberg, S. V.
    Schwartzman, K.
    Narita, M.
    Machado, E. S.
    Schluger, N. W.
    Lopez, M.
    Leung, C. -C.
    Chaisson, R. E.
    Belknap, R. W.
    Sanchez, J.
    Villarino, M. E.
    Sterling, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [29] SIMILAR ANTIHYPERTENSIVE EFFECT OF ONCE-DAILY AND TWICE-DAILY ENALAPRIL
    SARIS, S
    AFFRIME, MB
    LOWENTHAL, DT
    IRVIN, J
    VIAU, J
    DICKERMAN, D
    ONESTI, G
    CLINICAL RESEARCH, 1983, 31 (02): : A334 - A334
  • [30] Dapagliflozin twice daily or once daily: effect on pharmacokinetics and urinary glucose excretion in healthy subjects
    Tang, W.
    Reele, S.
    Hamer-Maansson, J. E.
    Parikh, S.
    de Bruin, T. W. A.
    DIABETES OBESITY & METABOLISM, 2015, 17 (04): : 423 - 425
12345